News News Details

Efung Capital Named to ChinaVenture's 2025 Top 30 Best VC Institutions in GBA

Date: 2025-12-19
Views: 0

Today, ChinaVenture Information released its "2025 Guangdong-Hong Kong-Macao Greater Bay Area Ranking." Efung Capital was named to ChinaVenture's 2025 Top 30 Best Venture Capital Institutions in the Greater Bay Area.

This ranking surveyed nearly 200 equity investment institutions and approximately 60 guidance funds in the Greater Bay Area. Adopting a combination of quantitative and qualitative methodologies, the evaluation assessed selected institutions based on criteria including assets under management, investment activity, and exit performance. The process involved initial screening, information verification, final ranking, and comprehensive consideration of each institution's market influence and reputation. Eligible investment institutions were ultimately selected based on their composite scores.

It is worth noting that a comparison of institutions over the past two years reveals that the earlier the investment stage, the more dramatic the changes among listed institutions. Specifically, at the early-stage venture capital level, the repeat rate is approximately 60%; at the venture capital stage, this rate increases to about 73%; and at the private equity stage, it further rises to roughly 80%. The high turnover rate at the early stage indicates a market full of opportunities and challenges, where new institutions can rapidly emerge through innovative strategies and precise investments. The relative stability at the middle and late stages reflects the market's pursuit of, long-term investment value, as well as the advantages of leading institutions in resource integration and risk management.

Looking ahead, Efung Capital will remain committed to its original aspiration of "addressing unmet clinical needs." The firm will continue to anchor itself in the biopharmaceutical sector, deeply long-term value that can transcend market cycles, take root in the Greater Bay Area, resonate with the pulse of local innovation, and help更 technology the gap from laboratory to industry. Efung firmly believes that the riverbed of time will ultimately uplift and reveal true value.


Related News / Recommended news More
2026 - 03 - 24
In March, Suzhou is gradually embracing the vitality of spring, much like China's biomedical industry, which is gathering momentum amidst transformation. On March 13, during the 11th BioChina Summit (BIOCHINA 2026), Mr. Zhu Pai, CEO of Efung Capital, was invited to attend the core session—the Global Investment Forum—where he engaged in in-depth discussions with industry peers on the theme &quo...
2026 - 03 - 25
Frontier Biotechnologies Inc. (“Frontier Biotechnologies” or the “Company”) recently entered into an exclusive licensing agreement with global biopharmaceutical company GlaxoSmithKline (“GSK”). Under the agreement, GSK will obtain exclusive worldwide rights for the development, manufacturing, and commercialization of two siRNA pipeline assets. One candidate drug has reached the Investigational New...
2026 - 03 - 06
Oryzogen's Orumin® Phase IV Clinical Trial Completes First Dosing | Portfolio NewsOn March 5, 2026, the Phase IV clinical study of Oryzogen's recombinant human albumin (rice-derived) Orumin®, evaluating its "safety and efficacy in patients with hypoalbuminemia and/or hypovolemia requiring emergency treatment," achieved its first patient enrollment and completed the init...
2026 - 03 - 05
The year 2026 marks the beginning of the 15th Five-Year Plan period. Recently, the 11th batch of the “Outstanding Domestic Medical Equipment Product Catalogue” was officially released. Viestar’s independently developed BIOPSEE® Confocal Laser Endomicroscope and BIOPSEE® Ultra-Thin Probe-based Confocal Laser Endomicroscope were prominently selected. This recognition makes JWS Medical the ...
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务